Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2000
05/10/2000CN1252280A Biological health article with immunity regulating function
05/10/2000CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds
05/09/2000US6060600 Substituted tetronic acids useful for treating HIV and other retroviruses
05/09/2000US6060597 Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060467 Graft survival prolongation with porphyrins
05/09/2000US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
05/09/2000US6060450 Administering tau-interferon to treat multiple sclerosis, rheumatoid arthritis, diabetes, and lupus
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060250 Human transferases
05/09/2000US6060064 Chimeric virus-like particle antigen presentation and delivery system
05/09/2000US6060061 Method for preventing or treating disorders involving an inflammatory process
05/09/2000US6060058 Vaccine for conferring bacterial immunity containing lactoferrin receptor protein
05/09/2000US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite)
05/09/2000US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
05/09/2000US6060054 Product for T lymphocyte immunosuppression
05/09/2000US6060049 Surrogate tolerogenesis for the development of tolerance to xenografts
05/09/2000CA2153584C Cytokine restraining agents
05/09/2000CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/04/2000WO2000025137A1 Assays for autoantibodies
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024899A2 Interleukin-1 homolog zil1a4
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/04/2000WO2000012072A3 The use of fumaric acid derivatives in transplant medicine
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway
05/04/2000WO1999054286A3 Btk inhibitors and methods for their identification and use
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348431A1 Interleukin-1 homolog zil1a4
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2342626A1 Substituted phenyl derivatives, their preparation and use
05/04/2000CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/03/2000EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
05/03/2000EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
05/03/2000EP0996721A2 Secreted proteins and polynucleotides encoding them
05/03/2000EP0996710A1 Component of bromelain
05/03/2000EP0996636A1 The ha-1 antigen
05/03/2000EP0996464A1 Multivalent in ovo avian vaccine
05/03/2000EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996440A1 Method for treatment of glutamate related disorders
05/03/2000EP0996438A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin
05/03/2000EP0669977B1 Transformed endothelial cells
05/03/2000EP0652768B1 A pharmaceutical preparation for the synergistic activation of natural killer cells
05/03/2000CN1252101A Component of bromelain
05/03/2000CN1252096A Component of bromelain
05/03/2000CN1252076A Production of antihuman antigen receptors and use thereof
05/03/2000CN1252075A Synthetic HIV GAG genes
05/03/2000CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1251996A Combination therapy for HIV infections
05/03/2000CN1251772A Process for extracting granulocyte stimulating factor and its compound polyose capsules
05/03/2000CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them
05/03/2000CN1051998C Isoquinolines preparation thereof and its medicinal compositions
05/02/2000US6057450 Derivatives of pyroglutaminic acid preparation process and applications
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
05/02/2000US6057336 Lactam metalloprotease inhibitors
05/02/2000US6057329 Inhibitors of the protein tyrosine kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases
05/02/2000US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use
05/02/2000US6057305 Antiretroviral enantiomeric nucleotide analogs
05/02/2000US6057295 Oligopeptides derived from C-reactive protein fragments
05/02/2000US6057294 Peptide
05/02/2000US6057292 Method for inhibiting growth hormone action
05/02/2000US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein
05/02/2000US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1)
05/02/2000US6057128 MU-1, member of the cytokine receptor family
05/02/2000US6057112 Ubiquitin conjugation proteins
05/02/2000US6056963 Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins
05/02/2000US6056959 CD40 antigen antibody complex
05/02/2000US6056957 Humanized monoclonal antibodies against human interleukin-5
05/02/2000US6056956 Non-depleting anti-CD4 monoclonal antibodies and tolerance induction
05/02/2000US6056938 Cationic lipids and the use thereof
05/02/2000US6055936 Sea cucumber carotenoid lipid fractions and process
05/02/2000CA2022740C Cyclic neurokinin a antagonists
05/02/2000CA2020838C Hemoregulatory peptides
05/02/2000CA2004784C Anti-aids virus agent 2-amino-6-chlorpurine-9-.beta.-2,'3'-dideoxyribofuranoside
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1172